Resources
Pivotal Phase III trial undergoes audits by the FDA and sponsor
Challenge: A pivotal Phase III clinical trial of C1 inhibitor for the prophylactic treatment of hereditary angioedema managed by ARG […]
June 1, 2018
Does Your CRO Innovate To Keep Trials On Track?
ARG knows from experience that the willingness to be flexible has fueled our success in rare disease clinical trials, resulting in approvals with over $3B in sales.
May 9, 2018
ARG successfully starts up a Phase II trial within 6 weeks
Challenge: In an economic downturn, small biotech companies often depend on clinical milestones in order to maximize shareholder value and […]
May 1, 2018
Is Your CRO a Genuine Operational Partner?
ARG's history of successfully operationalizing rare disease clinical research has been driven by comprehensive engagement with our sponsors.
April 6, 2018
Does Your CRO Attract and Retain Talent?
In a recent engagement survey, 98.6% of employees indicated they believe ARG cares about them, and 97.8% responded that they see themselves working for ARG for many years to come.
March 20, 2018
Does Your CRO Partner With a Specialty Pharmacy?
ARG is always exploring avenues to further leverage our unique relationships to provide additional value to our sponsors. This includes a one-of-a-kind partnership with a national specialty pharmacy.
March 6, 2018